COVID patients in Bloomington survive with help of monoclonal antibodies

With the increase in the number of coronavirus cases, once again there is a great demand for emergency monoclonal antibodies that successfully combat COVID-19.

Casirivimab, imdevimab bamlanivimab, etesevimab and sotrovimab save lives.

But since the treatment is in great demand, it has become difficult to obtain. The state now allocates the amount of antibody treatment each hospital receives. Studies show that it may not work well against a rapidly spreading omicron variant.

Tom Whitehead, a spokesman for Monroe Hospital, confirmed this week that doctors are screening those who are looking for antibodies, “it’s less available.” “The infusion is given to those at high risk of progressing to severe COVID-19, including hospitalization or death.”

Holiday wave:Holiday disruptions factor in doubling of COVID cases in Monroe County; Indiana cases rise

Leave a Reply

Your email address will not be published. Required fields are marked *